Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
The polio vaccine is one of the greatest public health achievements in history, virtually eliminating polio in the developed world. VAERS tracks adverse events for both the current inactivated vaccine (IPV) and the historical oral vaccine (OPV).
Important context: most IPV VAERS reports are from combination vaccines (like DTaP-IPV) where the polio component is given alongside other antigens. Side effects may be from the combination rather than the polio component specifically.
Common:
IPV is considered one of the safest vaccines. Serious adverse events directly attributable to IPV are extremely rare.
The oral polio vaccine (OPV) carried a very small risk of vaccine-associated paralytic polio (VAPP) — about 1 case per 2.4 million doses. This is why the U.S. switched exclusively to IPV in 2000. OPV is still used in some countries for its ability to provide intestinal immunity and stop wild poliovirus transmission.
IPV is given as a multi-dose series in childhood. See when each dose is due on the CDC vaccine schedule and our 2026 vaccine schedule analysis.
As of mid-2026, the polio vaccine continues to be monitored through VAERS and complementary surveillance systems including the Vaccine Safety Datalink (VSD) and the Clinical Immunization Safety Assessment (CISA) project. No new safety signals have been identified in recent data that would change the established safety profile of this vaccine.
The HHS administration's announced development of AI-powered VAERS analysis tools may provide additional insights into polio vaccine adverse event patterns. These tools aim to detect subtle signals that traditional statistical methods might miss, though their implementation timeline and methodology remain under development.
It's worth noting that VAERS reporting for routine vaccines like polio has remained stable through the post-pandemic period. While COVID-19 vaccine reports surged and then declined, reporting patterns for established childhood and adult vaccines have been remarkably consistent, suggesting that the VAERS system continues to function as designed for ongoing safety surveillance.
When interpreting VAERS data for polio vaccines, several key principles apply:
VAERS data is most useful as a starting point for conversation with your healthcare provider, not as a basis for medical decisions. If you're concerned about polio vaccine side effects:
For the most up-to-date safety information, consult the CDC's vaccine information pages or speak with a qualified healthcare professional.
As of mid-2026, the polio vaccine continues to be monitored through VAERS and complementary surveillance systems including the Vaccine Safety Datalink (VSD) and the Clinical Immunization Safety Assessment (CISA) project. No new safety signals have been identified in recent data that would change the established safety profile of this vaccine.
The HHS administration's announced development of AI-powered VAERS analysis tools may provide additional insights into polio vaccine adverse event patterns. These tools aim to detect subtle signals that traditional statistical methods might miss, though their implementation timeline and methodology remain under development.
It's worth noting that VAERS reporting for routine vaccines like polio has remained stable through the post-pandemic period. While COVID-19 vaccine reports surged and then declined, reporting patterns for established childhood and adult vaccines have been remarkably consistent, suggesting that the VAERS system continues to function as designed for ongoing safety surveillance.
When interpreting VAERS data for polio vaccines, several key principles apply:
VAERS data is most useful as a starting point for conversation with your healthcare provider, not as a basis for medical decisions. If you're concerned about polio vaccine side effects:
For the most up-to-date safety information, consult the CDC's vaccine information pages or speak with a qualified healthcare professional.